300 related articles for article (PubMed ID: 15639478)
1. Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3.
Milberg P; Reinsch N; Wasmer K; Mönnig G; Stypmann J; Osada N; Breithardt G; Haverkamp W; Eckardt L
Cardiovasc Res; 2005 Feb; 65(2):397-404. PubMed ID: 15639478
[TBL] [Abstract][Full Text] [Related]
2. Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3.
Milberg P; Reinsch N; Osada N; Wasmer K; Mönnig G; Stypmann J; Breithardt G; Haverkamp W; Eckardt L
Basic Res Cardiol; 2005 Jul; 100(4):365-71. PubMed ID: 15944809
[TBL] [Abstract][Full Text] [Related]
3. Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes.
Milberg P; Hilker E; Ramtin S; Cakir Y; Stypmann J; Engelen MA; Mönnig G; Osada N; Breithardt G; Haverkamp W; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):647-54. PubMed ID: 17388913
[TBL] [Abstract][Full Text] [Related]
4. Increasing gap junction coupling reduces transmural dispersion of repolarization and prevents torsade de pointes in rabbit LQT3 model.
Quan XQ; Bai R; Liu N; Chen BD; Zhang CT
J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1184-9. PubMed ID: 17711442
[TBL] [Abstract][Full Text] [Related]
5. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes.
Antzelevitch C; Sun ZQ; Zhang ZQ; Yan GX
J Am Coll Cardiol; 1996 Dec; 28(7):1836-48. PubMed ID: 8962574
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the Na+/Ca2+ exchanger suppresses torsades de pointes in an intact heart model of long QT syndrome-2 and long QT syndrome-3.
Milberg P; Pott C; Fink M; Frommeyer G; Matsuda T; Baba A; Osada N; Breithardt G; Noble D; Eckardt L
Heart Rhythm; 2008 Oct; 5(10):1444-52. PubMed ID: 18929333
[TBL] [Abstract][Full Text] [Related]
7. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
[TBL] [Abstract][Full Text] [Related]
8. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil.
Aiba T; Shimizu W; Inagaki M; Noda T; Miyoshi S; Ding WG; Zankov DP; Toyoda F; Matsuura H; Horie M; Sunagawa K
J Am Coll Cardiol; 2005 Jan; 45(2):300-7. PubMed ID: 15653031
[TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic effects of free polyunsaturated fatty acids in an experimental model of LQT2 and LQT3 due to suppression of early afterdepolarizations and reduction of spatial and temporal dispersion of repolarization.
Milberg P; Frommeyer G; Kleideiter A; Fischer A; Osada N; Breithardt G; Fehr M; Eckardt L
Heart Rhythm; 2011 Sep; 8(9):1492-500. PubMed ID: 21459164
[TBL] [Abstract][Full Text] [Related]
10. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
11. In vivo mechanisms precipitating torsades de pointes in a canine model of drug-induced long-QT1 syndrome.
Gallacher DJ; Van de Water A; van der Linde H; Hermans AN; Lu HR; Towart R; Volders PG
Cardiovasc Res; 2007 Nov; 76(2):247-56. PubMed ID: 17669388
[TBL] [Abstract][Full Text] [Related]
12. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome.
Antzelevitch C; Yan GX; Shimizu W
J Electrocardiol; 1999; 32 Suppl():158-65. PubMed ID: 10688320
[TBL] [Abstract][Full Text] [Related]
13. Ivabradine Aggravates the Proarrhythmic Risk in Experimental Models of Long QT Syndrome.
Frommeyer G; Weller J; Ellermann C; Leitz P; Kochhäuser S; Lange PS; Dechering DG; Eckardt L
Cardiovasc Toxicol; 2019 Apr; 19(2):129-135. PubMed ID: 30238354
[TBL] [Abstract][Full Text] [Related]
14. Experimental study on the mechanism of sex difference in the risk of torsade de pointes.
Ruan YF; Liu N; Zhou Q; Li Y; Wang L
Chin Med J (Engl); 2004 Apr; 117(4):538-41. PubMed ID: 15109445
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of pause-induced torsade de pointes in long QT syndrome.
Liu J; Laurita KR
J Cardiovasc Electrophysiol; 2005 Sep; 16(9):981-7. PubMed ID: 16174020
[TBL] [Abstract][Full Text] [Related]
16. Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsades de Pointes in models of acquired and congenital long QT syndrome.
Shimizu W; McMahon B; Antzelevitch C
J Cardiovasc Electrophysiol; 1999 Feb; 10(2):154-64. PubMed ID: 10090218
[TBL] [Abstract][Full Text] [Related]
17. Epicardial activation of left ventricular wall prolongs QT interval and transmural dispersion of repolarization: implications for biventricular pacing.
Fish JM; Di Diego JM; Nesterenko V; Antzelevitch C
Circulation; 2004 May; 109(17):2136-42. PubMed ID: 15078801
[TBL] [Abstract][Full Text] [Related]
18. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes.
Shimizu W; Antzelevitch C
Circulation; 1998 Nov; 98(21):2314-22. PubMed ID: 9826320
[TBL] [Abstract][Full Text] [Related]
19. Ryanodine-receptor inhibition by dantrolene effectively suppresses ventricular arrhythmias in an ex vivo model of long-QT syndrome.
Frommeyer G; Krawczyk J; Ellermann C; Bögeholz N; Kochhäuser S; Dechering DG; Fehr M; Eckardt L
J Cardiovasc Electrophysiol; 2018 Mar; 29(3):471-476. PubMed ID: 29314443
[TBL] [Abstract][Full Text] [Related]
20. Effects of sodium channel block with mexiletine to reverse action potential prolongation in in vitro models of the long term QT syndrome.
Sicouri S; Antzelevitch D; Heilmann C; Antzelevitch C
J Cardiovasc Electrophysiol; 1997 Nov; 8(11):1280-90. PubMed ID: 9395171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
